期刊文献+

Dysferlin蛋白缺陷的Miyoshi肌病的临床与病理学特点

Clinical and pathological features of Miyoshi myopathy with dysferlin protein deficient
下载PDF
导出
摘要 目的探讨dysferlin蛋白缺陷的Miyoshi肌病(MM)的临床与病理学特点。方法对3例MM患者的临床及病理资料进行分析。结果3例患者均为青少年起病,临床主要表现均为下肢远端无力伴肌肉明显萎缩,其中1例发病初期伴有小腿肌肉疼痛肿胀,1例下肢近端肌肉无力;3例患者血清肌酸磷酸激酶均明显升高,分别为7543IU/L、5657IU/L、8721IU/L;2例乳酸脱氢酶升高,分别为465IU/L、636IU/L。3例肌肉病理均为肌源性损害,肌细胞膜dysferlin蛋白明显缺失,dystrophin表达正常;其中1例肌肉病理有炎细胞浸润。结论MM患者均为青少年起病,临床以下肢无力及肌萎缩为特点,病理可见肌细胞膜dysferlin蛋白缺失。 Objective To investigate the clinical and pathological features of Miyoshi myopathy (MM) with dysferlin protein deficient. Methods The clinical and pathological data of the 3 patients with MM were analysed. Results 3 patients were onset at youngster. The clinical manifestation were myastheria and myoatrophy in distal of lower limbs. 1 case combined myalgia and tumefaction in lower limbs at early stage of onset ; 1 case showed myathenia in proximal of lower limbs. The level of serum creatine phosphokinase ( CK ) was significantly ligher in the 3 cases (7543 IU/L, 5657 IU/L, 8721 IU/L respectively). The level of serum lactic dehydrogenase (LDH) was significantly higher in the 2 cases (456 IU/L , 636 IU/L respectively). The result of muscle pathology was showed myogenic damage in all the cases. The expression of dysferlin protain in membrane of muscle cells was completely deficient, although the expression of dystrophin was normal. Inflammatory cells infiltration was found in 1 case's muscle tissue. Conclusions The clinical characters of MM patient are onset at youngster, myasthenia and myoatrophy in lower limbs. The deficit of dysferlin protain can be found by pathology.
出处 《临床神经病学杂志》 CAS 北大核心 2009年第1期16-18,共3页 Journal of Clinical Neurology
关键词 MIYOSHI肌病 临床表现 dysferlin蛋白 Miyoshi myopathy clinical manifestation dysferlin protein
  • 相关文献

参考文献10

  • 1Weiler T, Greenberg CR, Nylen E, et al. Limb-girdle muscular dystrophy and Miyoshi myopathy in an aboriginal Canadian kindred map to LGMD2B and segregate with the same haplotype [ J]. Am J Hum Genet, 1996, 59:872.
  • 2Bansal D, Campbell KP. Dysferlin and the plasma membrane repair in muscular dystrophy [J]. Trends Cell Biol, 2004, 14:206.
  • 3Illarioshkin SN, Ivanova-Smolenskaya IA, Greenberg CR, et al. Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy [ J ]. Neurology, 2000, 55 : 1931.
  • 4Ueyama H, Kumamoto T, Horinouehi H, et al. Clinical heterogeneity in dysferlinopathy [ J]. Intern Med, 2002, 41:532.
  • 5Miyoshi K, Kawai H, Iwasa M, et al. Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy. Seventeen cases in eight families including an autopsied case[ J ]. Brain, 1986, 109:31.
  • 6Argov Z, Sadeh M, Mazor K, et al. Muscular dystrophy due to dysferlin deficiency in Libyan Jews. Clinical and genetic features [ J]. Brain, 2000,123 : 1229.
  • 7Aoki M, Liu J, Richard I, et al. Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy [ J]. Neurology, 2001, 57:271.
  • 8Rowin J, Meriggioli MN, Cochran E J, et al. Prominent inflammatory changes on muscle biopsy in patients wilh Miyoshi myopathy [ J]. Neuromuscul Disord, 1999, 9:417.
  • 9Fanin M, Angelini C. Muscle pathology in dysferlin deficiency [ J]. Neuropathol Appl Neurobiol, 2002, 28:461.
  • 10Tagawa K, Ogawa M, Kawabe K, et al. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients [J]. J Neurol Sci, 2003, 211:23.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部